Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PRF1 | P14222 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12180779 | 1.00 | DPP4 (0.56) | DPP4APPCYP2A6CYP2E1CYP3A4 | |
| SCHEMBL2592381 | 0.98 | DPP4 (0.53) | DPP4APPCYP2A6CYP2E1CYP3A4 | |
| SCHEMBL607254 | 0.87 | DPP4 (0.69) | DPP4APPCYP2A6CYP2E1CYP3A4 | |
| SCHEMBL2014710 | 0.84 | — | — | |
| SCHEMBL278904 | 0.84 | DPP4 (0.65) | DPP4APPCYP2A6CYP2E1CYP3A4 | |
| SCHEMBL16140264 | 0.80 | DPP4 (0.62) | DPP4APPCYP2A6CYP2E1CYP3A4 | |
| SCHEMBL498510 | 0.79 | APP (0.33) | APPMAPTKDM4E | |
| SCHEMBL21156754 | 0.79 | APP (0.33) | APPMAPTKDM4E | |
| SCHEMBL2590561 | 0.76 | — | — | |
| SCHEMBL16574341 | 0.76 | DPP4 (0.45) | DPP4APPCYP2A6CYP2E1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9147848-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-09-29 | — | — | US | disclosed |
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-05-21 | — | — | US | disclosed |
| US-8975419-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-03-10 | — | — | US | disclosed |
| US-20140005411-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITE (HK) | 2014-01-02 | — | — | US | disclosed |
| EP-2566848-A1 | IMPROVED OLIGOTHIOPHENES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-03-13 | — | — | EP | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| WO-2011137487-A1 | IMPROVED OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011137487-A1 | IMPROVED OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-10 | — | — | WO | disclosed |
| WO-2010132952-A1 | OLIGOTHIOPHENES AND USE THEREOF IN DYE-SENSITISED SOLAR CELLS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | DSG1, CDC73, CDC23 | DPP4 1416/4885APP 2721/4885CYP2A6 3487/4885 |
| US-20130042918-A1 | OLIGOTHIOPHENES | NR0B2, NR2C2, NR1H2 | DPP4 4832/4885APP 2811/4885CYP2A6 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.